A patient with asthma is prescribed to use albuterol via inhaler before rigorous exercise. Which statement best describes the mode of action for this medication?

A. Albuterol is an anticholinergic causing dryness of bronchial secretions: Albuterol does not have anticholinergic properties and does not reduce secretions. Its primary action is bronchodilation, not secretion management. B. Albuterol stimulates the parasympathetic nervous system causing the heart rate to decrease.: Albuterol is not a parasympathetic stimulant and can actually cause mild tachycardia due to beta-1 effects. Decreasing heart rate is not part of its therapeutic action in asthma. C. Albuterol is a beta 2 adrenergic agonist which relaxes bronchial smooth muscle.: Albuterol selectively activates beta-2 receptors in the airways, causing smooth muscle relaxation and bronchodilation. This prevents exercise-induced bronchospasm and improves airflow, making it the first-line rescue medication for asthma. D. Albuterol is an antihistamine, causing a block in the histamine response.: Albuterol does not block histamine receptors and does not prevent allergic responses. Its mechanism targets beta-2 adrenergic receptors to dilate airways, not histamine pathways.